RAYDIAX and the STIMULATE research campus institutionalize long-term partnership
We are happy to announce our newest long-term partnership together with the Forschungscampus STIMULATE to deepen the clinical and technical. Together we will work on innovative research topics relating to minimally invasive therapies.
Dr. Thomas Hoffmann, CEO and co-founder of RAYDIAX: "Joining the STIMULATE association ensures that our company maintains clinical and technical excellence at all times. The globally expanded network has supported us as a start-up in all matters since its foundation. We are pleased to institutionalize this by joining the association."
Ready for Innovation?
We know that the methods of minimally invasive therapies continue to offer great potential for clinical innovation. Would you also like to establish your operating technique? Make a suggestion, define a joint project and research your case on our system in phantom studies. And of course we are open to clinical publications.
